Healthcare provider profile · identity verified

Tushar M Patel, M.D.

Allopathic & Osteopathic Physicians|Internal Medicine · LOWELL, MA · NPI 1376504399

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Tushar M Patel, M.D. received $137.97 in general payments during 2025 across 3 reported records.

Medtronic, Inc. accounted for 69.7% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$137.97

3 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Medtronic, Inc.	Medtronic, Inc. exact · evidence 2025-07-22	$96.14	69.7%	1	2025
Abbott Laboratories	Unresolved — no canonical attribution shown	$21.30	15.4%	1	2025
Bayer Healthcare Pharmaceuticals Inc.	Unresolved — no canonical attribution shown	$20.53	14.9%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$137.97	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
INTERSTIM Normalized: interstim	Device	Medtronic, Inc.	$96.14	1	2025
Source payment records 2025-01-15 · Medtronic, Inc. · $96.14 · Open Payments source
PROCLAIM Normalized: proclaim	Device	Abbott Laboratories	$21.30	1	2025
Source payment records 2025-06-27 · Abbott Laboratories · $21.30 · Open Payments source
Kerendia Normalized: kerendia	Drug	Bayer Healthcare Pharmaceuticals Inc.	$20.53	1	2025
Source payment records 2025-05-06 · Bayer Healthcare Pharmaceuticals Inc. · $20.53 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	663	213
Losartan Potassium	Losartan Potassium	526	167
Amlodipine Besylate	Amlodipine Besylate	505	161
Omeprazole	Omeprazole	426	140
Levothyroxine Sodium	Levothyroxine Sodium	369	93
Metformin Hcl	Metformin Hcl	329	89
Gabapentin	Gabapentin	288	61
Furosemide	Furosemide	280	91
Metoprolol Succinate	Metoprolol Succinate	237	66
Trazodone Hcl	Trazodone Hcl	220	52
Eliquis	Apixaban	217	35
Lisinopril	Lisinopril	214	59
Simvastatin	Simvastatin	205	50
Meloxicam	Meloxicam	204	84
Alprazolam	Alprazolam	187	50
Escitalopram Oxalate	Escitalopram Oxalate	186	45
Albuterol Sulfate Hfa	Albuterol Sulfate	166	58
Pravastatin Sodium	Pravastatin Sodium	155	52
Sertraline Hcl	Sertraline Hcl	145	41
Tramadol Hcl	Tramadol Hcl	142	33
Pantoprazole Sodium	Pantoprazole Sodium	138	33
Doxazosin Mesylate	Doxazosin Mesylate	133	29
Metoprolol Tartrate	Metoprolol Tartrate	129	32
Mirtazapine	Mirtazapine	126	23
Atenolol	Atenolol	123	40
Tamsulosin Hcl	Tamsulosin Hcl	118	43
Rosuvastatin Calcium	Rosuvastatin Calcium	116	41
Hydrochlorothiazide	Hydrochlorothiazide	114	42
Lorazepam	Lorazepam	112	20
Bupropion Xl	Bupropion Hcl	107	27
Labetalol Hcl	Labetalol Hcl	107	35
Fluticasone Propionate	Fluticasone Propionate	98	34
Alendronate Sodium	Alendronate Sodium	85	22
Buspirone Hcl	Buspirone Hcl	85	26
Clopidogrel	Clopidogrel Bisulfate	74	19
Prednisone	Prednisone	73	55
Zolpidem Tartrate	Zolpidem Tartrate	73	20
Citalopram Hbr	Citalopram Hydrobromide	71	22
Famotidine	Famotidine	69	20
Potassium Chloride	Potassium Chloride	67	23
Donepezil Hcl	Donepezil Hcl	62	16
Fluoxetine Hcl	Fluoxetine Hcl	61	14
Allopurinol	Allopurinol	60	22
Pioglitazone Hcl	Pioglitazone Hcl	59	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	56	21
Terazosin Hcl	Terazosin Hcl	55	19
Ropinirole Hcl	Ropinirole Hcl	53	11
Quetiapine Fumarate	Quetiapine Fumarate	52	suppressed
Glimepiride	Glimepiride	51	14
Oxybutynin Chloride Er	Oxybutynin Chloride	51	16
Glipizide	Glipizide	50	13
Montelukast Sodium	Montelukast Sodium	49	14
Trulicity	Dulaglutide	48	suppressed
Clonazepam	Clonazepam	47	suppressed
Xarelto	Rivaroxaban	47	suppressed
Celecoxib	Celecoxib	46	19
Hydrocortisone	Hydrocortisone	43	22
Valsartan	Valsartan	42	17
Finasteride	Finasteride	41	14
Carvedilol	Carvedilol	40	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	40	19
Fenofibrate	Fenofibrate	40	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	39	15
Incruse Ellipta	Umeclidinium Bromide	39	suppressed
Azelastine Hcl	Azelastine Hcl	36	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	12
Spironolactone	Spironolactone	36	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	14
Oxycodone Hcl	Oxycodone Hcl	35	11
Olanzapine	Olanzapine	33	suppressed
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Meclizine Hcl	Meclizine Hcl	32	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	24
Ozempic	Semaglutide	31	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Bupropion Hcl Sr	Bupropion Hcl	29	suppressed
Lidocaine	Lidocaine	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	27	suppressed
Amoxicillin	Amoxicillin	26	18
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	26	suppressed
Divalproex Sodium	Divalproex Sodium	26	suppressed
Glipizide Er	Glipizide	26	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	26	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Duloxetine Hcl	Duloxetine Hcl	25	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Baclofen	Baclofen	22	suppressed
Methenamine Hippurate	Methenamine Hippurate	22	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Primidone	Primidone	20	suppressed
Sulfasalazine	Sulfasalazine	20	suppressed
Azithromycin	Azithromycin	19	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Nystatin	Nystatin	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	17
Ezetimibe	Ezetimibe	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Cilostazol	Cilostazol	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Eszopiclone	Eszopiclone	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Metformin Hcl Er	Metformin Hcl	16	suppressed
Torsemide	Torsemide	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Timolol Maleate	Timolol Maleate	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	12	suppressed
Dexamethasone	Dexamethasone	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Naloxone Hcl	Naloxone Hcl	12	12
Rybelsus	Semaglutide	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Zaleplon	Zaleplon	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Naproxen	Naproxen	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$137.97 · 3 records	Medtronic, Inc.	INTERSTIM, Kerendia, PROCLAIM	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error